IR-Med Future Growth
Future criteria checks 5/6
IR-Med is forecast to grow earnings and revenue by 92.3% and 90.7% per annum respectively while EPS is expected to grow by 91.9% per annum.
Key information
92.3%
Earnings growth rate
91.9%
EPS growth rate
Medical Equipment earnings growth | 16.1% |
Revenue growth rate | 90.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 31 | 12 | N/A | N/A | 1 |
12/31/2025 | 15 | 4 | N/A | N/A | 1 |
12/31/2024 | 1 | -5 | N/A | N/A | 1 |
12/31/2023 | N/A | -5 | -3 | -3 | N/A |
9/30/2023 | N/A | -6 | -3 | -3 | N/A |
6/30/2023 | N/A | -5 | -3 | -3 | N/A |
3/31/2023 | N/A | -5 | -4 | -4 | N/A |
12/31/2022 | N/A | -5 | -3 | -3 | N/A |
9/30/2022 | N/A | -4 | -3 | -3 | N/A |
6/30/2022 | N/A | -4 | -3 | -3 | N/A |
3/31/2022 | N/A | -4 | -3 | -3 | N/A |
12/31/2021 | N/A | -4 | -3 | -2 | N/A |
9/30/2021 | N/A | -3 | -2 | -2 | N/A |
6/30/2021 | N/A | -2 | -1 | -1 | N/A |
3/31/2021 | N/A | -1 | -1 | -1 | N/A |
12/31/2020 | N/A | -1 | 0 | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IRME is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: IRME is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: IRME is expected to become profitable in the next 3 years.
Revenue vs Market: IRME's revenue (90.7% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: IRME's revenue (90.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IRME's Return on Equity is forecast to be high in 3 years time